Synaptive receives FDA clearance for point-of-care MRI

By staff writers

May 1, 2020 -- 3D visualization firm Synaptive Medical has garnered U.S. Food and Drug Administration (FDA) clearance for its Evry dedicated head MRI system.

Designed for point-of-care imaging in critical care settings, Evry features a 0.5-tesla superconducting magnet, predefined imaging protocols, automated series planning, a detachable stretcher to support beside transfers, and a multichannel head coil, according to the vendor. It also doesn't require yearly cryogen refills, a cryogen pipe, reinforced flooring, or rigging or cranes to be used for delivery, Synaptive said.

The Toronto-based firm previously received Health Canada approval for Evry in February.

Copyright © 2020

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking